Vol. 40 No. 11 2012
■ SERIES： From the Clinical Site
Off-label use of leukotriene receptor antagonist
T. Fujiwara
Jpn Pharmacol Ther 2012 40(11) 933-9
■ ORIGINAL ARTICLES
A 13-week feeding, subchronic toxicity study of maltosyl cyclodextrin mixture（ISOELEAT®）in Crl: CD（SD）rats
K. Mikuni, et al.
Jpn Pharmacol Ther 2012 40(11) 941-52
Bioequivalence study of improved modified formulation of cilostazol 100mg orally disintegrating tablet and currently marketed cilostazol 100mg orally disintegrating tablet
（Pletaal® OD Tablet 100mg）in healthy adult male subjects
S. Hasegawa, et al.
Jpn Pharmacol Ther 2012 40(11) 955-64
Bioequivalence study of two formulations（360 and 120μg/mL） of KRN321（darbepoetin alfa）in healthy volunteers
W. Yuji, et al.
Jpn Pharmacol Ther 2012 40(11) 965-71
Dose-ranging study of anagliptin in Japanese patients with type 2 diabetes
─A multi-centre, randomized, placebo-controlled, double-blind, parallel-group study─
K. Kaku
Jpn Pharmacol Ther 2012 40(11) 973-84
Efficacy and safety of anagliptin in Japanese patients with type 2 diabetes
─A multi-centre, randomized, placebo- and active comparator-controlled, double-blind, parallel-group study─
K. Kaku
Jpn Pharmacol Ther 2012 40(11) 985-95
Determination of serum epoetin beta pegol（MIRCERA®） concentration by double-antibody radioimmunoassay（RIA2 antibody assay）method for epoetin
M. Aoki, et al.
Jpn Pharmacol Ther 2012 40(11) 999-1004
The optimal conditions for use of the hydration patch, Win Back®, on human skin
K. Ooi, et al.
Jpn Pharmacol Ther 2012 40(11) 1005-10
Effects of capsinoids-containing dietary supplements on sensation of cold constitution and physical and psychological complaints in female students
T. Unno, et al.
Jpn Pharmacol Ther 2012 40(11) 1011-8
Effects of Chlorella administration on human serum lipid levels
I. Maruyama, et al.
Jpn Pharmacol Ther 2012 40(11) 1019-24
Safety evaluation regarding the intake of high dose diacylglycerol oil with reduced glycidol fatty acid esters
T. Mizuno, et al.
Jpn Pharmacol Ther 2012 40(11) 1025-33
